Adaptable Covalent Organic Framework‐Hydrogel Microneedles for Glucose‐Responsive Isoliquiritigenin Delivery in Diabetic Wound Therapy
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.71343 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Menghan Zhou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Plastic Surgery Institute, Shandong Provincial Key Laboratory for Tissue Regeneration and Reconstruction (Under Preparation), Shandong Second Medical…. Hauptthemen laut MEDLINE: Wound Healing, Diabetes Mellitus, Experimental, Chalcones, Glucose. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key R&D Program of China, Shandong Provincial Key Research and Development Program (Competitive Innovation Platform), Biomaterials and Regenerative Medicine Institute Cooperative Research Project of Shanghai Jiao Tong University School of Medicine.
Abstract (Originalsprache)
Effective management of diabetic wound healing remains a significant clinical challenge, primarily due to the persistent inflammatory microenvironment and the lack of effective sustained drug delivery strategies that promote tissue regeneration. This pathological stagnation is increasingly attributed to the overactivation of Z‐DNA binding protein 1 (ZBP1), a pivotal innate immune sensor that triggers pro‐inflammatory cascades under hyperglycemic conditions. In this study, we developed an adaptive covalent organic framework–hydrogel microneedle (ISL@bCOF‐MNs) for glucose‐responsive delivery of isoliquiritigenin (ISL). The system utilizes boron–oxygen bonds to conjugate the small‐molecule drug ISL with a covalent organic framework, which is integrated into microneedles composed of a biomimetic interfacial‐bonding nanocomposite hydrogel, which exhibits high transdermal permeability for deep dermal drug delivery. In vitro experiments show that the ISL@bCOF nanodrug dynamically releases ISL in response to hyperglycemic conditions, thereby suppressing inflammation and scavenging reactive oxygen species via targeting of ZBP1. In vivo studies confirm that the microneedle‐based transdermal delivery system effectively regulates inflammation and promotes full‐thickness wound healing in diabetic mouse models. This work elucidates a potential mechanism by which ISL targets ZBP1 to correct the inflammatory microenvironment and enhance collagen tissue regeneration with advanced biomaterials, offering a promising translational strategy for the clinical management of diabetic wounds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Plastic Surgery Institute, Shandong Provincial Key Laboratory for Tissue Regeneration and Reconstruction (Under Preparation), Shandong Second Medical University, Weifang, P. R. China.
- Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Key Laboratory of Tissue Engineering, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.
- National Tissue Engineering Center of China, Shanghai, P. R. China.
ORCID-Profile: Menghan Zhou, Guangdong Zhou, Yujie Hua, Di Wang
Förderung
- National Key R&D Program of China
- Shandong Provincial Key Research and Development Program (Competitive Innovation Platform)
- Biomaterials and Regenerative Medicine Institute Cooperative Research Project of Shanghai Jiao Tong University School of Medicine
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Natural Science Foundation of Shandong Province
- Shandong Province Higher Education Institutions Youth Creative Technology Support Programme
- Cross Research Fund Project of the Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine
Zitieren
APA
Zhou, M., Hu, Z., Li, X., Geng, H., Liu, Y., Wang, Y., Yang, Y., Zhou, G., Hua, Y., & Wang, D. (2026). Adaptable Covalent Organic Framework‐Hydrogel Microneedles for Glucose‐Responsive Isoliquiritigenin Delivery in Diabetic Wound Therapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71343
Vancouver
Zhou M, Hu Z, Li X, Geng H, Liu Y, Wang Y, et al. Adaptable Covalent Organic Framework‐Hydrogel Microneedles for Glucose‐Responsive Isoliquiritigenin Delivery in Diabetic Wound Therapy. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.71343
BibTeX
@article{Zhou2026,
author = {Zhou, Menghan and Hu, Zongjie and Li, Xiuwen and Geng, Huaman and Liu, Yang and Wang, Yajie and Yang, Yunshu and Zhou, Guangdong and Hua, Yujie and Wang, Di},
title = {Adaptable Covalent Organic Framework‐Hydrogel Microneedles for Glucose‐Responsive Isoliquiritigenin Delivery in Diabetic Wound Therapy},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.71343}
}
EUVIMED